Skip Main Navigation
Page Content
This event has ended

What’s Happening with Big Pharma and Neuroscience Development?

The Bioscience Network, Inc.

Thursday, August 15, 2013 from 5:30 PM to 9:00 PM (EDT)

What’s Happening with Big Pharma and Neuroscience...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Biotech / Pharma / Academia Professional (non service provider) Ended $35.00 $0.00
Vendor-Provider of products & services to biotech companies Ended $50.00 $0.00

Share What’s Happening with Big Pharma and Neuroscience Development?

Event Details

What’s Happening with Big Pharma and Neuroscience Development?

Date & Location
August 15, 2013

McGovern Institute at MIT


Event Description

What is going on?! In the last decade, many pharmaceutical companies have given up on neuroscience R&D. Finding funding for neurology-oriented startup biotech companies has been challenging for some time. Meanwhile, some companies have “doubled down” on neurology.


At BIO 2012, Governor Patrick announced the formation of the Massachusetts Neuroscience Consortium, “…a pioneering new model that is designed to leverage Massachusetts’ rich environment for purposes of accelerating early-stage research available to the pharmaceutical industry, introducing academic researchers to the challenges of targeted research, and facilitating industry-academic collaborations.” Participants include Abbott, Biogen Idec, EMD Serono, Janssen Research & Development, LLC, Merck, Pfizer and Sunovion. In April of this year, President Obama announced $100 million in federal funding for the BRAIN Project, “…a project to speed up the development and application of technologies that will help researchers create dynamic brain imaging, in order to learn how individual brain cells and complex neural circuits interact.


So why do some see neuroscience as vast opportunity and some see it as a black hole? Come hear leaders from academic research, big pharma and the investment community discuss this timely topic at MIT’s McGovern Institute.



5:30-6:30pm: Cocktails, Hors d'oeuvres and Networking
6:30-8:00pm: Panel Discussion
8:00-9:00pm: Networking


Liam Ratcliffe, MD PhD, General Partner, New Leaf Ventures


·     Guoping Feng, PhD Poitras Professor of Neuroscience, McGovern Institute for Brain Research at MIT

·      John Hennessey, Head of Business Operations, AstraZeneca Neuroscience

  • Mike Ehlers, MD, PhD  |  Neuroscience Chief Scientific Officer, Pfizer



The Bioscience Network (TBN) 
Where you are the future of life sciences


TBN is a non-profit organization providing networking and professional growth to individuals in the Bioscience industries.

Have questions about What’s Happening with Big Pharma and Neuroscience Development?? Contact The Bioscience Network, Inc.

When & Where

McGovern Institute at MIT
43 Vassar St
Cambridge, MA 02139

Thursday, August 15, 2013 from 5:30 PM to 9:00 PM (EDT)

  Add to my calendar

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.